AOD 9604, a synthetic fragment of growth hormone, has emerged as a potential therapeutic agent for optimizing fat loss. This peptide exerts its effects by targeting fat cells, promoting the elimination of triglycerides and reducing lipogenesis, the process of fat creation. Preclinical studies have demonstrated AOD 9604's ability to specifically add
Your Partner for FDA-Approved Peptides in the USA
When requiring a reliable partner for your peptide development journey in the United States, look no further than [Company Name]. As a leading CDMO specializing in peptides, we provide comprehensive capabilities from research and development to GMP production. Our commitment to quality is unwavering, ensuring all our peptides meet the stringent spe